Vagal Stimulation Ameliorates Non-Alcoholic Fatty Liver Disease in Rats.
Hany A ElkattawySamar Mortada MahmoudAhmed El-Sayed HassanAhmed BehiryHasnaa Ali EbrahimAteya Megahed IbrahimDonia Elsaid Fathi ZaghamirMohamed El SherbinySherein F El-SayedPublished in: Biomedicines (2023)
Our findings suggest that VNS may represent a promising therapeutic candidate for managing NAFLD induced by obesity. It can be considered to be an effective adjuvant physiological intervention for the obese population with NAFLD to spare the liver against obesity-induced deleterious injury.